Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key
Tailoring treatment in intermediate-risk pediatric Hodgkin lymphoma is feasible using an early response-based assessment for the omission of radiotherapy.